Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cannara Biotech (DE:8CB0)
FRANKFURT:8CB0
Cannara Biotech (8CB0) Stock Price & Analysis
0 Followers
8CB0 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.49 - €0.75
Previous Close€0.54
Volume0.00
Average Volume (3M)641.00
Market Cap
€46.93M
Enterprise Value€73.69M
Total Cash (Recent Filing)C$2.64M
Total Debt (Recent Filing)C$42.15M
Price to Earnings (P/E)N/A
Beta0.17
Next Earnings
Jul 25, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding90,018,952
10 Day Avg. Volume0
30 Day Avg. Volume641
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.89
Price to Sales (P/S)2.54
Price to Cash Flow (P/CF)51.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cannara Biotech News
PremiumCompany Announcements
Cannara Biotech Boasts Strong Q2 Growth
PremiumPress Releases
Cannara Biotech Reports Q2 2024 Financial Results
8CB0 FAQ
What was Cannara Biotech’s price range in the past 12 months?
Cannara Biotech lowest stock price was €0.49 and its highest was €0.75 in the past 12 months.
What is Cannara Biotech’s market cap?
Currently, no data Available
When is Cannara Biotech’s upcoming earnings report date?
Cannara Biotech’s upcoming earnings report date is Jul 25, 2024 which is in 70 days.
How were Cannara Biotech’s earnings last quarter?
Cannara Biotech released its earnings results on Apr 29, 2024. The company reported -€0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.026.
Is Cannara Biotech overvalued?
According to Wall Street analysts Cannara Biotech’s price is currently Overvalued.
Does Cannara Biotech pay dividends?
Cannara Biotech does not currently pay dividends.
What is Cannara Biotech’s EPS estimate?
Cannara Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannara Biotech have?
Currently, no data Available
What happened to Cannara Biotech’s price movement after its last earnings report?
Cannara Biotech reported an EPS of -€0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.885%.
Which hedge fund is a major shareholder of Cannara Biotech?
Currently, no hedge funds are holding shares in DE:8CB0
---
Cannara Biotech Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:8CB0 Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $112.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.09%
12-Months-Change
Fundamentals
Return on Equity
8.30%
Trailing 12-Months
Asset Growth
13.34%
Trailing 12-Months
Company Description
Cannara Biotech
Cannara Biotech Inc is engaged in production of indoor cannabis and derivative products for the Canadian and international markets. The company is building indoor cannabis cultivation facility in Quebec, Canada.
---
Technical Analysis
---